Literature DB >> 14763505

Hyperthermic preconditioning protects pig islet grafts from early inflammation but enhances rejection in immunocompetent mice.

Daniel Brandhorst1, Heide Brandhorst, Vidya Kumarasamy, Adel Maataoui, Alexandra Alt, Mathias D Brendel, Reinhard G Bretzel.   

Abstract

The induction of heat shock proteins (HSP) protects isolated islet cells against the cytotoxicity of inflammatory mediators in vitro. Very little information is available about the effect of HSP overexpression on function of preconditioned islet grafts. The present study investigated the function of heat-exposed pig islets after transplantation into immunocompetent mice in comparison with in vitro resistance against inflammatory mediators. Pig islets were preconditioned at 43 degrees C or sham treated prior to subcapsular transplantation into diabetic C57/Bl6j mice. Nondiabetic mice simultaneously receiving preconditioned and control islets were subjected to bilateral nephrectomy for determination of pig insulin. Resistance against H2O2, NO, human Il-1beta, IFN-gamma, or TNF-alpha was assessed by trypan blue exclusion and insulin determination. Heat-induced protein expression was confirmed by Western blot analysis. Graft preconditioning increased resistance against H2O2, NO, or cytokines (p < 0.05) but decreased survival in nondiabetic mice (p < 0.05) and function in diabetic mice (p < 0.01). Upregulation of caspase-3 activity as well as Bax, Fas, FasL, and DFF expression (p < 0.05) indicated simultaneous induction of apoptosis. The coexpression of HSP and proapoptotic proteins reveals the dual character of the stress response simultaneously starting mechanisms for protection and apoptosis. In vitro assays seem to reflect only insufficiently the situation of islets after transplantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14763505     DOI: 10.3727/000000003771000200

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  5 in total

Review 1.  Innate immunity and heat shock response in islet transplantation.

Authors:  Y Lai; C Chen; T Linn
Journal:  Clin Exp Immunol       Date:  2009-02-04       Impact factor: 4.330

2.  Standardized transportation of human islets: an islet cell resource center study of more than 2,000 shipments.

Authors:  John S Kaddis; Matthew S Hanson; James Cravens; Dajun Qian; Barbara Olack; Martha Antler; Klearchos K Papas; Itzia Iglesias; Barbara Barbaro; Luis Fernandez; Alvin C Powers; Joyce C Niland
Journal:  Cell Transplant       Date:  2012-08-10       Impact factor: 4.064

3.  Optimal Time to Ship Human Islets Post Tissue Culture to Maximize Islet.

Authors:  Barbara J Olack; Michael Alexander; Carol J Swanson; Julie Kilburn; Nicole Corrales; Antonio Flores; Jennifer Heng; Jayagowri Arulmoli; Keiko Omori; Peter J Chlebeck; Laura Zitur; Mayra Salgado; Jonathan R T Lakey; Joyce C Niland
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

4.  KU-32, a novel drug for diabetic neuropathy, is safe for human islets and improves in vitro insulin secretion and viability.

Authors:  Kevin Farmer; S Janette Williams; Lesya Novikova; Karthik Ramachandran; Sonia Rawal; Brian S J Blagg; Rick Dobrowsky; Lisa Stehno-Bittel
Journal:  Exp Diabetes Res       Date:  2012-11-01

5.  Toll-like receptor 4 deficiency accelerates the development of insulin-deficient diabetes in non-obese diabetic mice.

Authors:  Elke Gülden; Masaru Ihira; Atsushi Ohashi; Anna Lena Reinbeck; Marina A Freudenberg; Hubert Kolb; Volker Burkart
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.